...
首页> 外文期刊>BioSystems >Interaction between the immune system and acute myeloid leukemia: A model incorporating promotion of regulatory T cell expansion by leukemic cells
【24h】

Interaction between the immune system and acute myeloid leukemia: A model incorporating promotion of regulatory T cell expansion by leukemic cells

机译:免疫系统与急性髓性白血病的相互作用:一种促进白血病细胞调控性T细胞扩张的模型

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Population dynamics of regulatory T cells (Treg) are crucial for the underlying interplay between leukemic and immune cells in progression of acute myeloid leukemia (AML). The goal of this work is to elucidate the dynamics of a model that includes Treg, which can be qualitatively assessed by accumulating clinical findings on the impact of activated immune cell infusion after selective Treg depletion. We constructed an ordinary differential equation model to describe the dynamics of three components in AML: leukemic blast cells, mature regulatory T cells (Treg), and mature effective T cells (Teff), including cytotoxic T lymphocytes. The model includes promotion of Treg expansion by leukemic blast cells, leukemic stem cell and progenitor cell targeting by Teff, and Treg-mediated Teff suppression, and exhibits two coexisting, stable steady states, corresponding to high leukemic cell load at diagnosis or relapse, and to long-term complete remission. Our model is capable of explaining the clinical findings that the survival of patients with AML after allogeneic stem cell transplantation is influenced by the duration of complete remission, and that cut-off minimal residual disease thresholds associated with a 100% relapse rate are identified in AML. (C) 2018 Elsevier B.V. All rights reserved.
机译:调节性T细胞(Treg)的人口动态对于急性髓性白血病(AML)进展中白血病和免疫细胞之间的潜在相互作用至关重要。这项工作的目标是阐明包括Treg的模型的动态,这可以通过积累在选择性Treg耗尽后激活的免疫细胞输注的影响的临床发现来定性评估。我们构建了一种常规方程模型,来描述AML中的三种组分的动态:白血病爆炸细胞,成熟调节性T细胞(Treg)和成熟有效T细胞(Teff),包括细胞毒性T淋巴细胞。该模型包括通过Teff的白血病爆炸细胞,白血病干细胞和祖细胞促进Treg膨胀,并且Tree介导的Teff抑制,并且表现出两种共存,稳定的稳定状态,对应于诊断或复发的高白血病细胞负荷,以及长期完全缓解。我们的模型能够解释同种异体干细胞移植后AML患者的存活率受完全缓解持续时间的影响,并且在AML中鉴定了与100%复发率相关的切断最小的残留疾病阈值。 (c)2018 Elsevier B.v.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号